A multi-center clinical trial of Qianlieantong tablets for chronic prostatitis / 中华男科学杂志
National Journal of Andrology
; (12): 950-952, 2007.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-232032
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the efficacy and safety of Qianlieantong Tablets in the treatment of chronic prostatitis.</p><p><b>METHODS</b>A multi-center, self-controlled open clinical trial was conducted. A total of 280 subjects with chronic prostatitis were enrolled and treated by Qianlieantong Tablets, 3 times a day, 5 tablets each time. Before and after 2 and 4 weeks after the administration, NIH-CPSI scores and white blood cell counts in the prostate secretion were recorded.</p><p><b>RESULTS</b>Of the 273 subjects evaluated, the rates of excellence, effectiveness and ineffectiveness were 35.2% (n = 96), 47.6% (n = 130) and 17.2% (n = 47), respectively, with a total effectiveness rate of 82.8%. After 4 weeks'medication, the scores of the subjects on NIH-CPSI pain, voiding and quality of life and white blood cell counts in prostate secretion were significantly decreased compared with pre-treatment (P < 0.01). No adverse events or laboratory abnormality related to the medication were observed.</p><p><b>CONCLUSION</b>Qianlieantong Tablets has a significant effect on chronic prostatitis with high safety, particularly indicated in chronic prostatitis with pelvic pain.</p>
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Prostatite
/
Qualidade de Vida
/
Comprimidos
/
Esquema de Medicação
/
Medicamentos de Ervas Chinesas
/
Doença Crônica
/
Resultado do Tratamento
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Medicina Tradicional Chinesa
Tipo de estudo:
Ensaio clínico controlado
/
Estudo diagnóstico
Aspecto:
Preferência do paciente
Limite:
Adulto
/
Humanos
/
Masculino
Idioma:
Chinês
Revista:
National Journal of Andrology
Ano de publicação:
2007
Tipo de documento:
Artigo